NTLA - Intellia Therapeutics Inc
13.44
0.290 2.158%
Share volume: 3,311,227
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$13.15
0.29
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 28.935 M | 6.957 M | 9.111 M | 12.874 M | 16.627 M | 14.245 M | 13.782 M | 23.017 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 28.935 M | 6.957 M | 9.111 M | 12.874 M | 16.627 M | 14.245 M | 13.782 M | 23.017 M | |
| -75.96% | 30.96% | 41.30% | 29.15% | -14.33% | -3.25% | 67.01% | |||
| Operating expenses | 142.938 M | 146.000 M | 153.881 M | 149.321 M | 137.434 M | 124.241 M | 125.259 M | 121.727 M | |
| Selling general and admin | 31.091 M | 31.793 M | 30.501 M | 32.444 M | 29.007 M | 27.206 M | 30.512 M | 33.075 M | |
| Research and development | 111.847 M | 114.207 M | 123.380 M | 116.877 M | 108.427 M | 97.035 M | 94.747 M | 88.652 M | |
| Total expenses | 142.938 M | 146.000 M | 153.881 M | 149.321 M | 137.434 M | 124.241 M | 125.259 M | 121.727 M | |
| 2.14% | 5.40% | -2.96% | -7.96% | -9.60% | 0.82% | -2.82% | |||
| Operating income | -114.003 M | -139.043 M | -144.770 M | -136.447 M | -120.807 M | -109.996 M | -111.477 M | -98.710 M | |
| Ebit | -114.003 M | -139.251 M | -144.770 M | -135.508 M | -120.355 M | -110.400 M | -111.140 M | -98.668 M | |
| Pretax income | -107.436 M | -147.183 M | -135.712 M | -127.959 M | -113.877 M | -101.659 M | -100.987 M | -95.744 M | |
| 37.00% | -7.79% | -5.71% | -11.01% | -10.73% | -0.66% | -5.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -107.436 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||||
| Net income | -107.436 M | -146.975 M | -135.712 M | -128.898 M | -114.329 M | -101.255 M | -101.324 M | -95.786 M | |
| -36.80% | 7.66% | 5.02% | 11.30% | 11.44% | -0.07% | 5.47% |